Cytek Stock

cytekbio.comHealthcare / Other HealthcareFunding to Date: $81.75MM

Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services.

Register To Buy and Sell Shares

For more details on financing and valuation for Cytek, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cytek’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cytek.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Ming Yan Ph.D
Co-Founder, Chief Technology Officer & Board Member
Wenbin Jiang Ph.D
Co-Founder, Chief Executive Officer & Board Member
Eric Chase Ph.D
Chief Scientist & Board Member
Ken Riley
General Manager

Board Members

Kevin Yan
Xin Huang MD
Cowin Venture
Eric Chase Ph.D
Ming Yan Ph.D
Wenbin Jiang Ph.D

Frequently Asked Questions About Cytek’s Stock

Can you buy Cytek’s stock?
Cytek is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cytek’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cytek’s stock?
Yes, you can sell stock of a private company like Cytek. Forge can help you sell your Cytek stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cytek’s stock price?
Cytek is a privately held company and therefore does not have a public stock price. However, you may access Cytek’s private market stock price with Forge Data.
What is Cytek’s stock ticker symbol?
Cytek does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More
News items for the week of Feb. 21, 2022.
Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating
The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology.
Cytek Biosciences Adds Investors, Completes Series C Financing
Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum
Updated on: Jun 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.